“A Phase I II Feasibility Study of Intravenous Cetuximab in Combination With 5 Days Weekly Oral Capecitabine and Preoperative Radiotherapy in Rectal Cancer (XERXES)”. 2020. Archives of Clinical and Biomedical Research 4 (4): 394-412. https://fortunejournals.org/ojs/index.php/acbr/article/view/14778.